Previous 10 | Next 10 |
Penumbra (PEN): Q3 Non-GAAP EPS of $0.06 beats by $0.14; GAAP EPS of -$0.24 misses by $0.14.Revenue of $151.08M (+8.3% Y/Y) beats by $26.13M.Shares +3.13%.Press Release For further details see: Penumbra EPS beats by $0.14, beats on revenue
Penumbra, Inc. Reports Third Quarter 2020 Financial Results PR Newswire ALAMEDA, Calif., Oct. 28, 2020 ALAMEDA, Calif. , Oct. 28, 2020 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, t...
[[ACA]], [[AEM]], [[AFG]], [[AGI]], [[ALGT]], [[ALSN]], [[AM]], [[AMED]], [[AMGN]], [[AMP]], [[AR]], [[ASGN]], [[AVB]], [[AVT]], [[AVTR]], [[AXS]], [[BHE]], [[BLKB]], [[BOOT]], [[CACI]], [[CDE]], [[CERN]], [[CGNX]], [[CHDN]], [[CHX]], [[CNMD]], [[CONE]], [[CREE]], [[CTSH]], [[CUZ]], [[CW]], [...
Penumbra (NYSE:PEN) is scheduled to announce Q3 earnings results on Wednesday, October 28th, after market close.The consensus EPS Estimate is -$0.08 (-125.0% Y/Y) and the consensus Revenue Estimate is $124.95M (-10.4% Y/Y).Over the last 2 years, PEN has beaten EPS estimates 75% of the time an...
Penumbra, Inc. Schedules Third Quarter 2020 Earnings Release and Conference Call for October 28, 2020 PR Newswire ALAMEDA, Calif., Sept. 29, 2020 ALAMEDA, Calif. , Sept. 29, 2020 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will...
Axsome reports positive data from Major Depressive Disorder study. Penumbra suffers setback as new catheter falters. Enanta begins NASH clinical study for EDP-297. For further details see: Axsome Reports Positive Data, And Other News: The Good, Bad And Ugly Of Biopharma ...
Thinly traded Penumbra ( PEN -5.0% ) is under pressure on 26% higher volume, albeit on turnover of only 340K shares, in apparent reaction to an article from The Foundation for Financial Journalism on potential safety issues with the Jet 7 Xtra Flex, its newest aspiration catheter used in...
It's been a painful week for growth investors given significant declines in technology-oriented indexes and exchange traded funds. The NASDAQ 100 ETF ( QQQ ) fell over 11% from its intraday high this month to its intraday low this week, and returns were worse for software investors given the...
This article is part of a series that provides an ongoing analysis of the changes made to Generation Investment Management’s 13F portfolio on a quarterly basis. It is based on Al Gore’s regulatory 13F Form filed on 08/14/2020. Please visit our Tracking Al Gore’s Gener...
ALAMEDA, Calif. , Sept. 3, 2020 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Morgan Stanley 18th Annual Global Healthcare Conference on Thursday, September 17, 2020 . Event: ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-13 17:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-03 18:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Penumbra, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024 PR Newswire ALAMEDA, Calif. , July 2, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial resu...